H.R. 7830 · 117th Congress
Babies Need More Formula Now Act of 2022
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
StefanikSponsor49 cosponsors · 49 R
R
Bice
AH
R
Hinson
CM
R
McMorris Rodgers
RA
R
Allen
MB
R
Burgess
GB
R
Bilirakis
LB
R
Bucshon
KC
R
Cammack
BC
R
Carter
BF
R
Fitzpatrick
BG
R
Guthrie
HG
R
Griffith
RH
R
Hudson
DJ
R
Joyce
MK
R
Kelly
RL
R
Latta
BL
R
Long
DM
R
McKinley
AP
R
Pfluger
MS
R
Salazar
AS
R
Smith
GT
R
Thompson
CT
R
Tenney
TW
R
Walberg
DW
R
Webster
AW
R
Wagner
JW
R
Walorski
KA
R
Armstrong
MC
R
Cawthorn
BC
R
Cline
MC
R
Carey
PG
R
Gosar
CJ
R
Jacobs
YK
R
Kim
MM
R
Mullin
JM
R
Moolenaar
MM
R
Miller-Meeks
MF
R
Fischbach
AH
R
Harris
DH
R
Harshbarger
TB
R
Budd
BO
R
Owens
RW
R
Wittman
TE
R
Emmer
MG
R
Guest
MM
R
Miller
JR
R
Rutherford
BB
R
Babin
DV
R
Valadao3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill addresses the regulation of infant formula, including by authorizing the Food and Drug Administration (FDA) to waive certain requirements related to importation.
What it does: CRS summary · Introduced in House · May 18, 2022
Babies Need More Formula Now Act of 2022
This bill addresses the regulation of infant formula, including by authorizing the Food and Drug Administration (FDA) to waive certain requirements related to importation.
The FDA may waive labeling requirements related to the importation (or distribution or sale) of infant formula from a country with requirements that provide a similar assurance of safety as U.S. requirements.
The FDA must, when appropriate, enter into arrangements to harmonize U.S. regulatory requirements pertaining to infant formula with the requirements of other nations.
The bill imposes time lines for the FDA to respond to submissions for market approval for new infant formula.
The FDA must also issue guidance as to what types of changes in the ingredients of infant formula, if any, may not require a new growth study to meet FDA requirements.
The bill also authorizes a person to import, without prior notice to the FDA, up to a three-month supply of infant formula for personal use from a country with formula safety standards similar to U.S. standards, such as Canada.
Before recommending or requiring a recall of infant formula due exclusively to a labeling deficiency, the FDA must ensure that the recall will not negatively affect the supply of formula in the United States.
The bill also requires the FDA to (1) notify Congress no later than 24 hours after initiating a formula recall, and (2) provide certain information to formula manufacturers about restarting production after an inspection of a manufacturing facility impacted by a recall.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Babies Need More Formula Now Act of 2022
Latest action (May 18, 2022): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: May 18, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.